Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy

Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang · 2024

Read Lipocalin-2 promotes CKD vascular calcification by aggravating VSMCs ferroptosis through NCOA4/FTH1-mediated ferritinophagy by Yujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11607329.txt.

Description

Yujia Wang and nine co-authors show that lipocalin-2 drives vascular calcification in chronic kidney disease by worsening an iron linked cell death pathway. Calcification of vessels is a common complication of kidney disease with no effective therapy. High phosphate, a hallmark of the disease, triggers ferroptosis in vessel muscle cells, and lipocalin-2 handles iron traffic in cells.

High phosphate raises lipocalin-2 in arteries of patients, animal models, and cultured cells. Mice lacking the gene show far less calcification on a disease diet, while added lipocalin-2 worsens calcium deposits and cell state change. The mechanism runs through a ferritin eating pathway that frees iron and drives ferroptosis. Blocking that axis eases calcification in the models.

Catalog record

CREATORYujia Wang, Yuxia Zhang, Min Gao, Zhiqing Chen, Jing Lu, Yongqi Li, Yan Di, Yinan Zhao, Bicheng Liu, Rining Tang
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11607329

Browse the full library · About the Tower of Babel